What does DR. FRANKEN - DR. TER HAAR do?

DR. FRANKEN - DR. TER HAAR is a specialist medical practice in Antwerpen. Private Limited, started on 29 January 2021, 1 establishment.

What is the address of DR. FRANKEN - DR. TER HAAR?

The registered office of DR. FRANKEN - DR. TER HAAR is located at Leo Vermandellei 11, 2180 Antwerpen.

Is DR. FRANKEN - DR. TER HAAR still active?

Yes. According to the CBE (3 October 2026) DR. FRANKEN - DR. TER HAAR is active, legal situation “Normale toestand”, started on 29 January 2021.

Is DR. FRANKEN - DR. TER HAAR registered on Peppol?

Yes, DR. FRANKEN - DR. TER HAAR is registered on the Peppol network with ID 0208:0762697340.

What is the enterprise number of DR. FRANKEN - DR. TER HAAR?

The enterprise number of DR. FRANKEN - DR. TER HAAR is BE0762697340.

When was DR. FRANKEN - DR. TER HAAR founded?

DR. FRANKEN - DR. TER HAAR was founded on 29 January 2021.

Who are the directors of DR. FRANKEN - DR. TER HAAR?

According to the 2025 annual accounts, the directors of DR. FRANKEN - DR. TER HAAR are: Jan Franken, Eva ter Haar.

Is DR. FRANKEN - DR. TER HAAR a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 29 January 2021; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did DR. FRANKEN - DR. TER HAAR make in 2025?

DR. FRANKEN - DR. TER HAAR posted a profit after taxes of € 284,947 in financial year 2025.

What is the revenue of DR. FRANKEN - DR. TER HAAR?

As a small company, DR. FRANKEN - DR. TER HAAR is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 398,797.

DR. FRANKEN - DR. TER HAAR (Private Limited) - Antwerpen

Dossier DR. FRANKEN - DR. TER HAAR, printed on 3 October 2026 from databakkes.be/en/0762697340/dr-franken-dr-ter-haar. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. FRANKEN - DR. TER HAAR from Antwerpen, company number BE0762697340, closed financial year 2025 with a result of € 284,947 after tax. For that financial year DR. FRANKEN - DR. TER HAAR recorded a gross margin of € 398,797 and equity of € 227,552. Compared with financial year 2024, the result moved from € 341,606 to € 284,947. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 1, 2026.

What it is worth Healthy

€ 227,552

▼ 30% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 284,947

▼ 17% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 142,814

▼ 51% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 382,486 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 37,966

▲ 100% vs 2024

Of which on lease € 2,894.

Debts at end 2025

Bank debt

€ 3,039

▼ 77% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 70

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 53,528 Gross margin 2022: € 53,528 First fiscal year in the series	€ 340,579 Gross margin 2023: € 340,579 ▲ € 287,051 vs 2022 (€ 53,528) Favourable step	€ 471,070 Gross margin 2024: € 471,070 ▲ 38% vs 2023 (€ 340,579) Favourable step	€ 398,797 Gross margin 2025: € 398,797 ▼ 15% vs 2024 (€ 471,070) Unfavourable step	▼ 15%
Profit after taxes	€ 37,718 Profit after taxes 2022: € 37,718 First fiscal year in the series	€ 244,958 Profit after taxes 2023: € 244,958 ▲ € 207,240 vs 2022 (€ 37,718) Favourable step	€ 341,606 Profit after taxes 2024: € 341,606 ▲ 39% vs 2023 (€ 244,958) Favourable step	€ 284,947 Profit after taxes 2025: € 284,947 ▼ 17% vs 2024 (€ 341,606) Unfavourable step	▼ 17%
Equity	€ 379,704 Equity 2022: € 379,704 First fiscal year in the series	€ 507,015 Equity 2023: € 507,015 ▲ 34% vs 2022 (€ 379,704) Favourable step	€ 325,092 Equity 2024: € 325,092 ▼ 36% vs 2023 (€ 507,015) Unfavourable step	€ 227,552 Equity 2025: € 227,552 ▼ 30% vs 2024 (€ 325,092) Unfavourable step	▼ 30%
Total debts	€ 85,175 Total debts 2022: € 85,175 First fiscal year in the series	€ 59,204 Total debts 2023: € 59,204 ▼ 30% vs 2022 (€ 85,175) Favourable step	€ 42,004 Total debts 2024: € 42,004 ▼ 29% vs 2023 (€ 59,204) Favourable step	€ 11,868 Total debts 2025: € 11,868 ▼ 72% vs 2024 (€ 42,004) Favourable step	▼ 72%
Cash	€ 253,563 Cash 2022: € 253,563 First fiscal year in the series	€ 96,537 Cash 2023: € 96,537 ▼ 62% vs 2022 (€ 253,563) Unfavourable step	€ 289,825 Cash 2024: € 289,825 ▲ 200% vs 2023 (€ 96,537) Favourable step	€ 142,814 Cash 2025: € 142,814 ▼ 51% vs 2024 (€ 289,825) Unfavourable step	▼ 51%
Retained profit	€ 378,704 Retained profit 2022: € 378,704 First fiscal year in the series	€ 506,015 Retained profit 2023: € 506,015 ▲ 34% vs 2022 (€ 378,704) Favourable step	€ 324,092 Retained profit 2024: € 324,092 ▼ 36% vs 2023 (€ 506,015) Unfavourable step	€ 226,552 Retained profit 2025: € 226,552 ▼ 30% vs 2024 (€ 324,092) Unfavourable step	▼ 30%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 117,647 Dividend 2023: € 117,647 Unchanged (€ 0) Unchanged	€ 523,529 Dividend 2024: € 523,529 ▲ € 405,882 vs 2023 (€ 117,647) Unchanged	€ 382,486 Dividend 2025: € 382,486 ▼ 27% vs 2024 (€ 523,529) Unchanged	▼ 27%
Bank debt	€ 33,031 Bank debt 2022: € 33,031 First fiscal year in the series	€ 23,129 Bank debt 2023: € 23,129 ▼ 30% vs 2022 (€ 33,031) Favourable step	€ 13,132 Bank debt 2024: € 13,132 ▼ 43% vs 2023 (€ 23,129) Favourable step	€ 3,039 Bank debt 2025: € 3,039 ▼ 77% vs 2024 (€ 13,132) Favourable step	▼ 77%
Balance sheet total	€ 464,879 Balance sheet total 2022: € 464,879 First fiscal year in the series	€ 566,219 Balance sheet total 2023: € 566,219 ▲ 22% vs 2022 (€ 464,879) Unchanged	€ 367,096 Balance sheet total 2024: € 367,096 ▼ 35% vs 2023 (€ 566,219) Unchanged	€ 239,421 Balance sheet total 2025: € 239,421 ▼ 35% vs 2024 (€ 367,096) Unchanged	▼ 35%

Key figures of DR. FRANKEN - DR. TER HAAR, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. FRANKEN - DR. TER HAAR?

What happened at DR. FRANKEN - DR. TER HAAR in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 1, 2026 New annual accounts for financial year 2025: profit of € 284,947 (▼ 17% vs 2024). Source: NBB ↗
Jan 29, 2021 New establishment in Antwerpen. KBO
Jan 29, 2021 Start of the company according to the CBE. KBO

In short

From € 37,718 profit in 2022 to € 284,947 profit in 2025.

Paid € 287,331 in corporate taxes since 2022.

Best year ever: 2024, with € 341,606 profit.

Paid out € 1 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. FRANKEN - DR. TER HAAR? We notify you, reason included.

Follow DR. FRANKEN - DR. TER HAAR

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Jan Franken Eva ter Haar

DR. FRANKEN - DR. TER HAAR

BLURRY GROUP

Behind DR. FRANKEN - DR. TER HAAR are Jan Franken and Eva ter Haar. Eva ter Haar is also behind BLURRY GROUP.

See the full network in the app

Directors

According to the 2025 annual accounts

Jan Franken

Director

Eva ter Haar

Director

Also active at: BLURRY GROUP

Establishments

Establishment units

Physical locations of this company

Registered office

Leo Vermandellei 11

2180 Antwerpen

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0762.697.340
VAT number: BE 0762.697.340
Registered office: Leo Vermandellei 11, 2180 Antwerpen
Names & denominations: DR. FRANKEN - DR. TER HAAR
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 29 January 2021
Peppol: Active · Active since 24 Nov 2023
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗